Estadístiques de First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN

Visites totals

views
First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN 3

Visites totals per mes

views
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 3
April 2025 0

Visites al fitxer

views
Martinez_bcr_firs.pdf 21